Product information

Current status:

Cancelled Pre Market

Product name:

MIRALUMA

DIN:

Not Applicable Electronic product monograph is not available

Company:

LANTHEUS MI CANADA INC
1111 Dr. Frederik-Philips Blvd., Suite 600
Montreal
Quebec
Canada H4M 2X6

Class:

Radiopharmaceutical

Dosage form(s):

Powder For Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

Schedule C

American Hospital Formulary Service (AHFS): ^{See footnote 3}

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

Active ingredient group (AIG) number:^{See footnote5}

0152590001